Literature DB >> 30959374

RhoA inhibitor suppresses the production of microvesicles and rescues high ventilation induced lung injury.

Huijun Dai1, Suisui Zhang1, Xueke Du1, Weikang Zhang1, Ren Jing1, Xiaoxia Wang1, Linghui Pan2.   

Abstract

Microvesicles (MVs) have been extensively identified in various biological fluids including bronchoalveolar lavage fluid (BALF), peripheral blood and ascitic fluids. Our previous study showed that MVs are responsible for acute lung injury, but the exact mechanism underlying MVs formation remains poorly understood. In the present study, we investigate the potential role of RhoA/Rock signaling in MVs generation and the biological activity of MVs in ventilator-induced lung injury (VILI). Our results revealed that high tide ventilation induced super MVs releasing into the lung and subsequently caused lung inflammation. Strikingly, intratracheal instillation of MVs that isolated from highly ventilated mice triggered significant lung inflammation in naive mice. The MVs production is strongly correlated with lung inflammation and the upregulation of RhoA, Rock and phospho-Limk (phosphorylation of Limk is the activated form). RhoA inhibitor decreased the expression of Rock and the phosphorylation of Limk, decreased MVs production and alleviated lung inflammation. Rock inhibitor also decreased the phosphorylation of Limk, decreased MVs production and alleviated lung inflammation. Our data demonstrated that the production of MVs requires RhoA/Rock signaling, and VILI might be potentially prevented by targeting RhoA/Rock signaling pathway.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Lung injury; Microvesicles; RhoA/Rock signaling; Ventilator

Mesh:

Substances:

Year:  2019        PMID: 30959374     DOI: 10.1016/j.intimp.2019.03.059

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  9 in total

1.  Upregulation of sphingosine kinase 1 contributes to ventilator-associated lung injury in a two-hit model.

Authors:  Yan Wang; Ting-Ting Gao; Dun-Feng Xu; Xiao-Yan Zhu; Wen-Wen Dong; Zhou Lv; Yu-Jian Liu; Lai Jiang
Journal:  Int J Mol Med       Date:  2019-10-21       Impact factor: 4.101

Review 2.  EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases.

Authors:  Lukasz Zareba; Jacek Szymanski; Zuzanna Homoncik; Malgorzata Czystowska-Kuzmicz
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 3.  Adipocyte-Derived Extracellular Vesicles: State of the Art.

Authors:  Sophie Rome; Alexia Blandin; Soazig Le Lay
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

4.  Long non-coding RNA NEAT1 participates in ventilator-induced lung injury by regulating miR-20b expression.

Authors:  Yi Liu; Gang Tang; Jinyu Li
Journal:  Mol Med Rep       Date:  2022-01-04       Impact factor: 2.952

Review 5.  Extracellular Vesicles Physiological Role and the Particular Case of Disease-Spreading Mechanisms in Polyglutamine Diseases.

Authors:  Ricardo Moreira; Liliana S Mendonça; Luís Pereira de Almeida
Journal:  Int J Mol Sci       Date:  2021-11-13       Impact factor: 5.923

6.  Mechanosensitive cation channel Piezo1 contributes to ventilator-induced lung injury by activating RhoA/ROCK1 in rats.

Authors:  Yang Zhang; Lulu Jiang; Tianfeng Huang; Dahao Lu; Yue Song; Lihui Wang; Ju Gao
Journal:  Respir Res       Date:  2021-09-21

Review 7.  Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment.

Authors:  Yuanxin Xu; Kuanhan Feng; Huacong Zhao; Liuqing Di; Lei Wang; Ruoning Wang
Journal:  Theranostics       Date:  2022-01-16       Impact factor: 11.556

Review 8.  Unconventional Protein Secretion Dependent on Two Extracellular Vesicles: Exosomes and Ectosomes.

Authors:  Jacopo Meldolesi
Journal:  Front Cell Dev Biol       Date:  2022-06-09

9.  Inhibition of IP3R/Ca2+ Dysregulation Protects Mice From Ventilator-Induced Lung Injury via Endoplasmic Reticulum and Mitochondrial Pathways.

Authors:  Liu Ye; Qi Zeng; Maoyao Ling; Riliang Ma; Haishao Chen; Fei Lin; Zhao Li; Linghui Pan
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.